Literature DB >> 32868455

Exploring cellular biochemistry with nanobodies.

Ross W Cheloha1,2, Thibault J Harmand1,2, Charlotte Wijne1,2, Thomas U Schwartz3, Hidde L Ploegh4,2.   

Abstract

Reagents that bind tightly and specifically to biomolecules of interest remain essential in the exploration of biology and in their ultimate application to medicine. Besides ligands for receptors of known specificity, agents commonly used for this purpose are monoclonal antibodies derived from mice, rabbits, and other animals. However, such antibodies can be expensive to produce, challenging to engineer, and are not necessarily stable in the context of the cellular cytoplasm, a reducing environment. Heavy chain-only antibodies, discovered in camelids, have been truncated to yield single-domain antibody fragments (VHHs or nanobodies) that overcome many of these shortcomings. Whereas they are known as crystallization chaperones for membrane proteins or as simple alternatives to conventional antibodies, nanobodies have been applied in settings where the use of standard antibodies or their derivatives would be impractical or impossible. We review recent examples in which the unique properties of nanobodies have been combined with complementary methods, such as chemical functionalization, to provide tools with unique and useful properties.
© 2020 Cheloha et al.

Entities:  

Keywords:  antibody engineering; cell signaling; protein chemistry; single-domain antibody (SdAb); synthetic biology

Year:  2020        PMID: 32868455      PMCID: PMC7650250          DOI: 10.1074/jbc.REV120.012960

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  235 in total

1.  Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo.

Authors:  Friedrich Koch-Nolte; Jan Reyelt; Britta Schössow; Nicole Schwarz; Felix Scheuplein; Stefan Rothenburg; Friedrich Haag; Vanina Alzogaray; Ana Cauerhff; Fernando A Goldbaum
Journal:  FASEB J       Date:  2007-06-15       Impact factor: 5.191

2.  Anti-survivin single-domain antibodies derived from an artificial library including three synthetic random regions by in vitro selection using cDNA display.

Authors:  Takeru Suzuki; Yuki Mochizuki; Shinnosuke Kimura; Yoko Akazawa-Ogawa; Yoshihisa Hagihara; Naoto Nemoto
Journal:  Biochem Biophys Res Commun       Date:  2018-08-14       Impact factor: 3.575

Review 3.  Emerging site-specific bioconjugation strategies for radioimmunotracer development.

Authors:  Sam Massa; Catarina Xavier; Serge Muyldermans; Nick Devoogdt
Journal:  Expert Opin Drug Deliv       Date:  2016-05-13       Impact factor: 6.648

Review 4.  Recent advances in the selection and identification of antigen-specific nanobodies.

Authors:  Wenshuai Liu; Haipeng Song; Quan Chen; Jianli Yu; Mo Xian; Rui Nian; Dongxiao Feng
Journal:  Mol Immunol       Date:  2018-02-22       Impact factor: 4.407

5.  NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.

Authors:  Sandrine Moutel; Nicolas Bery; Virginie Bernard; Laura Keller; Emilie Lemesre; Ario de Marco; Laetitia Ligat; Jean-Christophe Rain; Gilles Favre; Aurélien Olichon; Franck Perez
Journal:  Elife       Date:  2016-07-19       Impact factor: 8.140

6.  Enhanced mRNA-protein fusion efficiency of a single-domain antibody by selection of mRNA display with additional random sequences in the terminal translated regions.

Authors:  Kazuki Takahashi; Masato Sunohara; Takuya Terai; Shigefumi Kumachi; Naoto Nemoto
Journal:  Biophys Physicobiol       Date:  2017-02-11

7.  Improved GPCR ligands from nanobody tethering.

Authors:  Ross W Cheloha; Fabian A Fischer; Andrew W Woodham; Eileen Daley; Naomi Suminski; Thomas J Gardella; Hidde L Ploegh
Journal:  Nat Commun       Date:  2020-04-29       Impact factor: 14.919

8.  Allosteric modulation of the GTPase activity of a bacterial LRRK2 homologue by conformation-specific Nanobodies.

Authors:  Margaux Leemans; Christian Galicia; Egon Deyaert; Elise Daems; Linda Krause; Jone Paesmans; Els Pardon; Jan Steyaert; Arjan Kortholt; Frank Sobott; Dagmar Klostermeier; Wim Versées
Journal:  Biochem J       Date:  2020-03-13       Impact factor: 3.857

9.  A toolbox of anti-mouse and anti-rabbit IgG secondary nanobodies.

Authors:  Tino Pleiner; Mark Bates; Dirk Görlich
Journal:  J Cell Biol       Date:  2017-12-20       Impact factor: 10.539

10.  Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor.

Authors:  Kathryn E Livingston; Jacob P Mahoney; Aashish Manglik; Roger K Sunahara; John R Traynor
Journal:  Elife       Date:  2018-06-22       Impact factor: 8.140

View more
  22 in total

1.  Protein visualization and manipulation in Drosophila through the use of epitope tags recognized by nanobodies.

Authors:  Jun Xu; Ah-Ram Kim; Ross W Cheloha; Fabian A Fischer; Joshua Shing Shun Li; Yuan Feng; Emily Stoneburner; Richard Binari; Stephanie E Mohr; Jonathan Zirin; Hidde L Ploegh; Norbert Perrimon
Journal:  Elife       Date:  2022-01-25       Impact factor: 8.140

2.  Single-domain near-infrared protein provides a scaffold for antigen-dependent fluorescent nanobodies.

Authors:  Olena S Oliinyk; Mikhail Baloban; Charles L Clark; Erin Carey; Sergei Pletnev; Axel Nimmerjahn; Vladislav V Verkhusha
Journal:  Nat Methods       Date:  2022-05-23       Impact factor: 47.990

3.  Strategies for targeting cell surface proteins using multivalent conjugates and chemical biology.

Authors:  Shivani Sachdev; Chino C Cabalteja; Ross W Cheloha
Journal:  Methods Cell Biol       Date:  2021-07-12       Impact factor: 1.829

4.  Generation and characterization of a laforin nanobody inhibitor.

Authors:  Zoe R Simmons; Savita Sharma; Jeremiah Wayne; Sheng Li; Craig W Vander Kooi; Matthew S Gentry
Journal:  Clin Biochem       Date:  2021-04-05       Impact factor: 3.625

5.  O-GlcNAc Engineering on a Target Protein in Cells with Nanobody-OGT and Nanobody-splitOGA.

Authors:  Daniel H Ramirez; Yun Ge; Christina M Woo
Journal:  Curr Protoc       Date:  2021-05

6.  Discovery and Characterization of an ALFA-Tag-Specific Affinity Resin Optimized for Protein Purification at Low Temperatures in Physiological Buffer.

Authors:  Markus Kilisch; Hansjörg Götzke; Maja Gere-Becker; Alexander Crauel; Felipe Opazo; Steffen Frey
Journal:  Biomolecules       Date:  2021-02-12

7.  A nanobody suite for yeast scaffold nucleoporins provides details of the nuclear pore complex structure.

Authors:  Sarah A Nordeen; Kasper R Andersen; Kevin E Knockenhauer; Jessica R Ingram; Hidde L Ploegh; Thomas U Schwartz
Journal:  Nat Commun       Date:  2020-12-02       Impact factor: 14.919

8.  Protein manipulation using single copies of short peptide tags in cultured cells and in Drosophila melanogaster.

Authors:  M Alessandra Vigano; Clara-Maria Ell; Manuela M M Kustermann; Gustavo Aguilar; Shinya Matsuda; Ning Zhao; Timothy J Stasevich; Markus Affolter; George Pyrowolakis
Journal:  Development       Date:  2021-03-16       Impact factor: 6.868

9.  Activity-based, bioorthogonal imaging of phospholipase D reveals spatiotemporal dynamics of GPCR-Gq signaling.

Authors:  Dongjun Liang; Ross W Cheloha; Tomoyuki Watanabe; Thomas J Gardella; Jeremy M Baskin
Journal:  Cell Chem Biol       Date:  2021-06-22       Impact factor: 8.116

Review 10.  Nanobodies: new avenue to treat kidney disease.

Authors:  Nicola Wanner; Thomas Eden; Nastassia Liaukouskaya; Friedrich Koch-Nolte
Journal:  Cell Tissue Res       Date:  2021-06-16       Impact factor: 4.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.